<?xml version="1.0" encoding="UTF-8"?>
<p id="par0050">Intra-host genomic variability also leads to antigenic variability, which is of higher importance, especially for pathogens that fail to elicit long-lasting immunity in their hosts, and remains a major contributor to the complexity of vaccine design [
 <xref rid="bib0145" ref-type="bibr">29</xref>,
 <xref rid="bib0150" ref-type="bibr">30</xref>]. To date, there are no clinically approved vaccines available for protection of general population from SARS- and MERS-CoV infections as there is no effective vaccine to induce robust cell mediated and humoral immune responses [
 <xref rid="bib0155" ref-type="bibr">31</xref>,
 <xref rid="bib0160" ref-type="bibr">32</xref>].
</p>
